Compare Synchrony Financial (SYF) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Synchrony Financial vs Tenet Healthcare Corporation — how do they compare? Synchrony Financial trades at $72.23 (market cap $24.69B), while Tenet Healthcare Corporation trades at $196.03 (market cap $16.74B). The key difference: Synchrony Financial is the larger of the two by market cap, and Synchrony Financial pays a 1.63% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| SYF | THC | |
|---|---|---|
Market Cap | $24.69B | $16.74B |
Sector | Financials | Health |
52-Week High | $88.47 | $244.80 |
52-Week Low | $63.78 | $148.38 |
Dividend Yield | 1.63% | — |
Enterprise Value | — | $26.99B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Synchrony Financial (SYF) trades at $73.41, down 0.29% with a bearish technical signal. The stock shows strong fundamentals with a P/E of 7.62, net income margin of 24.06%, and consistent earnings beats. Recent corporate actions include a $0.30 dividend payment in May 2026. Cash flow remains positive despite projected 2026 challenges. Technical indicators show mixed signals with RSI at neutral levels but bearish moving averages.
SYF presents value opportunity with attractive valuation metrics and strong profitability, though facing near-term technical headwinds. Key risks include economic sensitivity as a consumer lender and potential margin pressure from rising rates. Analyst consensus remains bullish with $86.38 price target representing 17.7% upside potential from current levels.
Tenet Healthcare (THC) trades at $194.38, down 0.27% on the day, with a neutral technical signal despite strong fundamental performance. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $4.82 exceeding expectations of $4.17. Valuation metrics appear attractive with a P/E of 10.14 and P/S of 0.79, while profitability remains robust with 82.47% gross margins and 37.87% ROE. Recent news highlights the company's expanding outpatient footprint through USPI as a key growth driver.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and a $235.88 price target representing 21% upside potential. The company's solid earnings momentum and defensive healthcare positioning during market volatility provide stability. Key risks include execution challenges in outpatient expansion and potential regulatory headwinds affecting hospital operations. Cash flow trends show improvement with projected net cash flow narrowing from -$136M in 2025 to -$32M in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Synchrony Financial
Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.
Read more on SYF →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
